Archive: Company News
MetrioPharm Establishes Scientific Advisory Board of Seasoned Immunology and Pediatric Experts
— The new advisors will supply expertise in immunology, pathology, inflammatory processes and in MetrioPharm’s lead indication Duchenne muscular dystrophy
— Advisors have previously collaborated with MetrioPharm on strategic and scientific projects
— Advisors bring expertise to further advance MetrioPharm´s pipeline
MetrioPharm AG, a clinical stage biotech company developing drugs for inflammatory and infectious diseases, today announced that it has established a Scientific Advisory Board (SAB). Read more…